Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fentanyl + levobupivacaine is a combination analgesic and local anesthetic formulation being evaluated by Assiut University for the management of postoperative pain. Specifically, it is used topically on nasal packing to reduce the pain associated with the removal of these packs following endoscopic nasal surgery. Fentanyl is a potent synthetic opioid that acts as a mu-opioid receptor agonist, providing systemic and local analgesia. Levobupivacaine is a long-acting local anesthetic that blocks voltage-gated sodium channels, preventing the initiation and conduction of nerve impulses. By combining these two agents, the treatment aims to provide superior pain relief compared to local anesthesia alone during the distressing procedure of nasal pack removal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fentanyl + levobupivacaine.